ISTITUTO REGINA ELENA Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rimini Italy (1933)

Organization Overview

First Clinical Trial
2002
NCT00911443
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Department of Anaesthesiology, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144 Roma (Italy); Tel. +39 0652662942, FAX: +39 0652662993; e-mail: forastiere@ifo.it | First Steps Wellness Centre, Regina | First Steps Wellness Centre, Winnipeg | IFO Polo Oncologico Ist. Regina Elena, Divisione Oncologia Medica A - ROMA | IFO Polo Oncologico Ist. Regina Elena, Roma | ISTITUTI FISIOTERAPICI OSPITALIERI- IFO - ISTITUTO REGINA ELENA | Istituto Nazionale Tumori "Regina Elena" | ISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALI | Marco G Paggi, MD, PhD | Regina Elena Cancer Institute | Regina Elena National Cancer Institute Via Elio Chianesi 53, 00144 Rome, Italy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Glioblastoma (Phase 2)

Hypersensitivity (Phase 2)

Melanoma (Phase 2)

Ovarian Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 29